C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1997
10/30/1997	CA2250425A1 Novel protein - traf6
10/30/1997	CA2242544A1 Improved production of insecticidal proteins
10/29/1997	EP0803574A2 Retrovirus-mediated secretion of recombinant products
10/29/1997	EP0803573A1 Polycistronic expression construct with cytokines for multivalent vaccines
10/29/1997	EP0803572A2 Cpc gene for regulating initiation of root hair formation for arabidopsis (thaliana), and transgenic (arabidopsis) plant overexpressing the cpc gene
10/29/1997	EP0803571A2 Tab1 protein & dna coding therefor
10/29/1997	EP0803570A1 Mutant human insulin receptor dna
10/29/1997	EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997	EP0802986A1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802984A1 Use of prolactin for preventing and/or treating bird broodiness
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997	EP0802980A1 Nucleic acid immunization using a virus-based infection/transfection system
10/29/1997	EP0802979A1 Secreted viral proteins useful for vaccines and diagnostics
10/29/1997	EP0802977A1 HARD AND SOFT WHEAT THIOREDOXINS h, HOMOLOGOUS PROTEINS, DNA FRAGMENTS CODING FOR SAID PROTEINS AND METHODS FOR PREPARING SAME
10/29/1997	EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997	EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0802795A1 Neurological drug screens
10/29/1997	EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997	EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997	EP0573435B1 Acellular vaccine
10/29/1997	EP0548191B1 Separation of proteins and dyes
10/29/1997	CN1163656A Axial flow valve system for linear compressor
10/29/1997	CN1163635A Macrophage derived chemokine and chemokine analogs
10/29/1997	CN1163620A Gradual modification super-agonists and antagonists of signal-proteins and peptides
10/29/1997	CN1163619A Antigenic polypeptide of chlamydia pneumoniae
10/29/1997	CN1163574A Acylated insulin analogs
10/28/1997	US5681960 Immunoassay
10/28/1997	US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997	US5681942 Fanconi Anemia Type C gene
10/28/1997	US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997	US5681936 Method of purification of recombinant human interleukin-5
10/28/1997	US5681934 47-kilodalton antigen of Treponema pallidum
10/28/1997	US5681933 Immunizing animal with interleukin
10/28/1997	US5681931 Polypeptides
10/28/1997	US5681928 Acylation, alkylation of an aminoglycine; insertion into peptide
10/28/1997	US5681926 Thrombin receptor binding peptides
10/28/1997	US5681925 Trifunctional antithrombin and antiplatelet peptides
10/28/1997	US5681923 Tumor derived carbohydrate binding protein
10/28/1997	US5681818 Therapeutic uses of human somatomedin carrier proteins
10/28/1997	US5681817 Treatment of ovarian estrogen dependent conditions
10/28/1997	US5681815 Antiviral and antitumor agents
10/28/1997	US5681814 Formulated IGF-I Composition
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681810 Diphtheria toxin fragments, conjugates and methods of use to inhibit tumors and leukemia
10/28/1997	US5681809 Growth hormone antagonists
10/28/1997	US5681750 Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use
10/28/1997	US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997	US5681746 Genetic engineering
10/28/1997	US5681745 Biotin-binding containment systems
10/28/1997	US5681731 Adeno-associated virus transducing vector having cellular tropism of different parvovirus, comprising gene encoding capsid protein of said parvovirus, other exogenous genetic material
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/28/1997	US5681723 Mutant interleukin 6 with improved biological activity over wild interleukin 6
10/28/1997	US5681721 Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect
10/28/1997	US5681720 DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
10/28/1997	US5681719 Genetic engineering
10/28/1997	US5681718 Butyric acid, or sodium salt thereof
10/28/1997	US5681717 Isolated dna sequence from brevibacterium is used for genetic engineering of other bacteria which can produce desired amino acids or nucleic acids as culture products
10/28/1997	US5681716 Nucleic acid sequences from Salmonella typhi for in vitro diagnosis in foodstuffs
10/28/1997	US5681715 Process for preparing lipases
10/28/1997	US5681714 Nucleic acid encoding tek receptor tyrosine kinase
10/28/1997	US5681713 Genetic engineering
10/28/1997	US5681708 Dissociate protein-protein complex
10/28/1997	US5681707 Useful in diagnosing diseases related to metabolism of the bones
10/28/1997	US5681701 Testing a drug by exposing a culture of the osteoblastic cells which express a temperature sensitive mutant of simian virus large t antigen to the drug and monitoring the effect
10/28/1997	US5681700 Prognosis of nephritis by determination of presence of immunoglobulin g antibodies cross-reactive with antibodies to double stranded dna and denatured anti-a and d snrnp proteins in a lupus patient
10/28/1997	US5681699 Assaying nucleic acid sample for the presence of a codon encoding arginine at amino acid position 241 of intercellular adhesion molecule-1
10/28/1997	US5681696 Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
10/28/1997	US5681570 A conjugate of capsular polysaccharide of streptococcus strain linked to p6 outer membrane protein of the haemophillus influenza strain
10/28/1997	US5681562 Lymphokine gene therapy of cancer
10/28/1997	US5681541 (oligo or poly)peptides
10/28/1997	CA1339515C Diagnostic system for the detection of cytomegalovirus
10/26/1997	CA2199582A1 Cpc gene for regulating initiation of root hair formation for arabidopsis (thaliana), and transgenic (arabidopsis) plant overexpressing the cpc gene
10/23/1997	WO1997039357A1 Wnt RECEPTOR COMPOSITIONS AND METHODS
10/23/1997	WO1997039135A1 Enhanced expression of transgenes
10/23/1997	WO1997039134A1 Virus-like particle
10/23/1997	WO1997039133A1 Novel neuronal cell growth factor
10/23/1997	WO1997039132A1 Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
10/23/1997	WO1997039131A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997	WO1997039129A1 Non-a-non-e hepatitis virus having a translatable core region, reagents and methods for their use
10/23/1997	WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997	WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997	WO1997039126A1 Novel rantes homolog from prostate
10/23/1997	WO1997039124A1 Cytoplasmic modulators of integrin regulation/signaling
10/23/1997	WO1997039123A2 Secreted proteins
10/23/1997	WO1997039122A2 ISOLATED AND CLONED MAST CELL 78 kDa PHOSPHOPROTEIN (MAST CELL DEGRANULATION INHIBITORY AGENT) AND USE THEREOF
10/23/1997	WO1997039121A1 Advanced glycosylation end-product receptor peptides and uses therefor
10/23/1997	WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	WO1997039118A1 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
10/23/1997	WO1997039110A1 Transgenic plants expressing geminivirus genes
10/23/1997	WO1997039109A1 Cell culture process and medium, cellular composition obtained and its application as production system and study model
10/23/1997	WO1997039105A1 Mad-related genes in the human
10/23/1997	WO1997039102A2 Secreted proteins
10/23/1997	WO1997039033A1 Purification of factor viii complex by immunoaffinity chromatography
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997039031A1 Glucagon-like peptide-2 analogs
10/23/1997	WO1997039030A2 Secreted proteins
10/23/1997	WO1997039029A2 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof

1 ... 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 ... 2916